Qube Research & Technologies (QRT)
RANI icon

Qube Research & Technologies (QRT)’s Rani Therapeutics RANI Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34.9K Sell
47,508
-100,718
-68% -$129K ﹤0.01% 3228
2025
Q4 		$200K Buy
+148,226
New +$224K ﹤0.01% 3060
2024
Q3 		– Sell
-3
Closed -$12 – 3961
2024
Q2 		$12 Hold
3
– – ﹤0.01% 3604
2024
Q1 		$9 Hold
3
– – ﹤0.01% 4300
2023
Q4 		$10 Hold
3
– – ﹤0.01% 4168
2023
Q3 		$7 Buy
+3
New +$11 ﹤0.01% 3951
2023
Q2 		– Sell
-19,907
Closed -$103K – 2893
2023
Q1 		$103K Buy
+19,907
New +$120K ﹤0.01% 2118

Other funds holding RANI

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCP
SymBiosis Capital Partners Bentonville, Arkansas $52.8M AUM
LP
Longaeva Partners Chicago, Illinois $2.7B AUM 37.16% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

Qube Research & Technologies (QRT)'s RANI Position: Q1 2026 in Review

Qube Research & Technologies (QRT) reduced its Rani Therapeutics (RANI) stake by 68% in Q1 2026, selling an estimated $129K and leaving 47,508 shares worth $34.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3228.

Qube Research & Technologies (QRT) first reported a position in RANI in Q1 2023 and has held it in 7 quarters since. The position peaked at $200K in Q4 2025. 74 funds tracked by Wall St. Rank hold RANI as of Q1 2026.

  • Qube Research & Technologies (QRT) held 47,508 shares of Rani Therapeutics worth $34.9K as of Q1 2026.
  • Qube Research & Technologies (QRT) sold 100,718 Rani Therapeutics shares in Q1 2026, an estimated $129K.
  • Rani Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #3228 holding.
  • Qube Research & Technologies (QRT) first reported a position in Rani Therapeutics in Q1 2023 and has held it in 7 quarters since.
  • Qube Research & Technologies (QRT)'s Rani Therapeutics position peaked at $200K in Q4 2025.
  • 74 funds tracked by Wall St. Rank held Rani Therapeutics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.